The global high potency API contract manufacturing market size is predicted to grow at a 7% CAGR from 2022 to 2032, according to a recently released FMI analysis. At the conclusion of the assessment period, the market is anticipated to be valued at US$8 billion. Rising breakthroughs in high potency API (HPAPI) manufacturing technologies, combined …